Theratechnologies Share Price Today
(NASDAQ: THTX)

Name: Theratechnologies Share Price Today (NASDAQ: THTX) - Theratechnologies Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Theratechnologies share price is $1.64 & ₹142.63 as on 6 Mar 2025, 2.30 'hrs' IST

$1.64

▲

0.04

(2.5%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Theratechnologies share price in Dollar and Rupees. Guide to invest in Theratechnologies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Theratechnologies, along with analyst recommendations, forecasts, and comprehensive financials.

Theratechnologies share price movements

Today's Low: $1.57
Today's High: $1.64
$1.64
3.97%
Downside
Day's Volatility :3.98%
Upside
0.01%
52 Weeks Low: $1.08
52 Weeks High: $2.18
$1.64
34.15%
Downside
52 Weeks Volatility :50.46%
Upside
24.77%

Theratechnologies (THTX) Returns

Period	Theratechnologies Inc	Index (Russel 2000)
3 Months	6.67%	0.0%
6 Months	29.55%	0.0%
1 Year	16.79%	0.0%
3 Years	-85.45%	-11.6%

Theratechnologies (THTX) Key Statistics

in dollars & INR

Previous Close	$1.6
Open	$1.62
Today's High	$1.6401
Today's Low	$1.5749
Market Capitalization	$75.9M
Today's Volume	$22.2K
52 Week High	$2.18
52 Week Low	$1.08
Revenue TTM	$85.9M
EBITDA	$10.6M
Earnings Per Share (EPS)	$-0.17
Profit Margin	-9.67%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1116.86%

How to invest in Theratechnologies Stock (THTX) from India?

It is very easy for Indian residents to invest directly in Theratechnologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Theratechnologies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Theratechnologies or THTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Theratechnologies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Theratechnologies shares which would translate to 0.530 fractional shares of Theratechnologies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Theratechnologies, in just a few clicks!

Returns in Theratechnologies (THTX) for Indian investors in Rupees

The Theratechnologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Theratechnologies investment value today

Current value as on today

₹1,24,671

Returns

₹24,671

(+24.67%)

Returns from Theratechnologies Stock

₹19,708 (+19.71%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Theratechnologies (THTX)

-40%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Theratechnologies Stock from India on INDmoney has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Theratechnologies

Soleus Capital Management, L.P.
10.44%
AIGH Capital Management, LLC
6.58%
Nantahala Capital Management, LLC
5.83%
Morgan Stanley - Brokerage Accounts
5.03%
Advisor Group Holdings, Inc.
0.32%
HARBOUR INVESTMENTS, INC.
0.19%

Analyst Recommendation on Theratechnologies

Buy

81%Buy

18%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Theratechnologies(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Theratechnologies Stock (THTX)

What analysts predicted

Upside of 129.23%

Target:

$3.76

Current:

$1.64

Insights on Theratechnologies Stock (Ticker Symbol: THTX)

Increasing Revenue
Revenue is up for the last 4 quarters, 22.01M → 25.00M (in $), with an average increase of 4.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 3.09M → -7.90M (in $), with an average decrease of 355.7% per quarter
THTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 51.2%
THTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 132.8%
Price to Sales
ForTHTX every $1 of sales, investors are willing to pay $0.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

THTX Theratechnologies Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$63.2M	↑ 43.49%
Net Income	$-12.5M	↑ 176.21%
Net Profit Margin	-19.77%	↓ 9.5%

	FY20	Y/Y Change
Revenue	$66.1M	↑ 4.49%
Net Income	$-22.7M	↑ 81.39%
Net Profit Margin	-34.32%	↓ 14.55%

	FY21	Y/Y Change
Revenue	$69.8M	↑ 5.71%
Net Income	$-31.7M	↑ 39.96%
Net Profit Margin	-45.44%	↓ 11.12%

	FY22	Y/Y Change
Revenue	$80.1M	↑ 14.66%
Net Income	$-47.2M	↑ 48.9%
Net Profit Margin	-59.0%	↓ 13.56%

	FY23	Y/Y Change
Revenue	$81.8M	↑ 2.13%
Net Income	$-24.0M	↓ 49.28%
Net Profit Margin	-29.3%	↑ 29.7%

	FY24	Y/Y Change
Revenue	$85.9M	↑ 5.02%
Net Income	$-8.3M	↓ 65.33%
Net Profit Margin	-9.67%	↑ 19.63%

	Q3 FY23	Q/Q Change
Revenue	$20.9M	↑ 0.0%
Net Income	$-746.0K	↑ 0.0%
Net Profit Margin	-3.58%	↑ 0.0%

	Q4 FY23	Q/Q Change
Revenue	$23.5M	↑ 12.45%
Net Income	$-2.8M	↑ 269.3%
Net Profit Margin	-11.75%	↓ 8.17%

	Q1 FY24	Q/Q Change
Revenue	$22.0M	↓ 6.15%
Net Income	$987.0K	↓ 135.83%
Net Profit Margin	4.48%	↑ 16.23%

	Q2 FY24	Q/Q Change
Revenue	$22.6M	↑ 2.68%
Net Income	$3.1M	↑ 213.17%
Net Profit Margin	13.68%	↑ 9.2%

	Q3 FY24	Q/Q Change
Revenue	$22.6M	↑ 0.0%
Net Income	$3.1M	↑ 0.0%
Net Profit Margin	13.68%	↑ 0.0%

	Q4 FY24	Q/Q Change
Revenue	$25.0M	↑ 10.63%
Net Income	$-7.9M	↓ 355.68%
Net Profit Margin	-31.61%	↓ 45.29%

	FY19	Y/Y Change
Profit	$37.1M	↑ 26.43%

	FY20	Y/Y Change
Profit	$39.2M	↑ 5.41%

	FY21	Y/Y Change
Profit	$46.6M	↑ 18.93%

	FY22	Y/Y Change
Profit	$53.8M	↑ 15.5%

	FY23	Y/Y Change
Profit	$62.1M	↑ 15.53%

	FY24	Y/Y Change
Profit	$65.4M	↑ 5.29%

	Q3 FY23	Q/Q Change
Profit	$15.9M	↑ 0.0%

	Q4 FY23	Q/Q Change
Profit	$18.4M	↑ 15.72%

	Q1 FY24	Q/Q Change
Profit	$17.1M	↓ 6.97%

	Q2 FY24	Q/Q Change
Profit	$18.1M	↑ 5.7%

	Q3 FY24	Q/Q Change
Profit	$18.1M	↑ 0.0%

	Q4 FY24	Q/Q Change
Profit	$18.9M	↑ 4.57%

	FY19	Y/Y Change
Operating Cash Flow	$-3.4M	↑ 915.09%
Investing Cash Flow	$-130.0K	↓ 98.69%
Financing Cash Flow	$-6.8M	↓ 114.53%

	FY20	Y/Y Change
Operating Cash Flow	$-13.6M	↑ 299.71%
Investing Cash Flow	$4.8M	↓ 3773.85%
Financing Cash Flow	$-7.2M	↑ 6.2%

	FY21	Y/Y Change
Operating Cash Flow	$-14.5M	↑ 6.81%
Investing Cash Flow	$-12.5M	↓ 360.76%
Financing Cash Flow	$37.9M	↓ 623.77%

	FY22	Y/Y Change
Operating Cash Flow	$-14.7M	↑ 1.49%
Investing Cash Flow	$8.7M	↓ 169.71%
Financing Cash Flow	$9.7M	↓ 74.5%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$5.3M	↑ 0.0%
Investing Cash Flow	$558.0K	↓ 23.98%
Financing Cash Flow	$-7.9M	↑ 0.0%

Theratechnologies Technicals Summary

Sell

Neutral

Buy

Theratechnologies is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Theratechnologies (THTX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Theratechnologies Inc	9.59%	29.55%	16.79%	-85.45%	-84.31%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Theratechnologies Inc	NA	NA	NA	0.0	-11.17	0.08	NA	-0.55
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Theratechnologies Inc	Buy	$75.9M	-84.31%	NA	-9.67%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Theratechnologies

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Organization	Theratechnologies
Employees	0
CEO	Mr. Paul Lévesque
Industry	Health Technology

Management People of Theratechnologies

Name	Title
Mr. Paul Lévesque	President, CEO & Director
Mr. Philippe Dubuc M.B.A., MBA	Senior VP & CFO
Mr. Jocelyn Lafond L.L.M., LL.B.	General Counsel & Corporate Secretary
Dr. Christian Marsolais Ph.D.	Senior VP & Chief Medical Officer
Mr. John Leasure	Global Commercial Officer
Ms. Joanne Choi	Senior Director of Investor Relations
Hon. Andre Dupras M.Sc.	Vice President of Human Resources

Important FAQs about investing in THTX Stock from India :

What is Theratechnologies share price today?

Theratechnologies share price today stands at $1.64, Open: $1.62 ; Previous Close: $1.60 ; High: $1.64 ; Low: $1.57 ; 52 Week High: $2.18 ; 52 Week Low: $1.08.

The stock opens at $1.62, after a previous close of $1.60. The stock reached a daily high of $1.64 and a low of $1.57, with a 52-week high of $2.18 and a 52-week low of $1.08.

Can Indians buy Theratechnologies shares?

Yes, Indians can invest in the Theratechnologies (THTX) from India.

With INDmoney, you can buy Theratechnologies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Theratechnologies at zero transaction cost.

How can I buy Theratechnologies shares from India?

It is very easy to buy Theratechnologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Theratechnologies (THTX) be purchased?

Yes, you can buy fractional shares of Theratechnologies with INDmoney app.

What are the documents required to start investing in Theratechnologies stocks?

To start investing in Theratechnologies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.